Laurel Wealth Advisors (North Carolina)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72K | Buy |
29,194
+29,090
| +27,971% | +$71.7K | ﹤0.01% | 529 |
|
|
2025
Q1 | $51.8K | Hold |
104
| – | – | 0.01% | 308 |
|
|
2024
Q4 | $54.1K | Sell |
104
-11
| -10% | -$5.72K | 0.01% | 303 |
|
|
2024
Q3 | $71.1K | Hold |
115
| – | – | 0.01% | 274 |
|
|
2024
Q2 | $63.6K | Sell |
115
-15
| -12% | -$8.3K | 0.01% | 270 |
|
|
2024
Q1 | $75.6K | Buy |
130
+32
| +33% | +$18.6K | 0.01% | 255 |
|
|
2023
Q4 | $52K | Hold |
98
| – | – | 0.01% | 277 |
|
|
2023
Q3 | $49.6K | Hold |
98
| – | – | 0.01% | 274 |
|
|
2023
Q2 | $51.1K | Hold |
98
| – | – | 0.01% | 279 |
|
|
2023
Q1 | $56.5K | Hold |
98
| – | – | 0.01% | 268 |
|
|
2022
Q4 | $54K | Hold |
98
| – | – | 0.01% | 251 |
|
|
2022
Q3 | $50K | Buy |
98
+11
| +13% | +$5.61K | 0.01% | 253 |
|
|
2022
Q2 | $47K | Sell |
87
-38
| -30% | -$20.5K | 0.01% | 261 |
|
|
2022
Q1 | $74K | Hold |
125
| – | – | 0.02% | 245 |
|
|
2021
Q4 | $83K | Buy |
125
+15
| +14% | +$9.96K | 0.02% | 233 |
|
|
2021
Q3 | $63K | Hold |
110
| – | – | 0.01% | 254 |
|
|
2021
Q2 | $55K | Buy |
110
+15
| +16% | +$7.5K | 0.01% | 269 |
|
|
2021
Q1 | $43K | Hold |
95
| – | – | 0.01% | 281 |
|
|
2020
Q4 | $44K | Buy |
95
+24
| +34% | +$11.1K | 0.01% | 269 |
|
|
2020
Q3 | $31K | Hold |
71
| – | – | 0.01% | 279 |
|
|
2020
Q2 | $26K | Sell |
71
-23
| -24% | -$8.42K | 0.01% | 288 |
|
|
2020
Q1 | $27K | Buy |
94
+48
| +104% | +$13.8K | 0.01% | 269 |
|
|
2019
Q4 | $15K | Hold |
46
| – | – | ﹤0.01% | 350 |
|
|
2019
Q3 | $13K | Buy |
46
+22
| +92% | +$6.22K | ﹤0.01% | 355 |
|
|
2019
Q2 | $7K | Sell |
24
-22
| -48% | -$6.42K | ﹤0.01% | 408 |
|
|
2019
Q1 | $13K | Hold |
46
| – | – | ﹤0.01% | 342 |
|
|
2018
Q4 | $10K | Buy |
+46
| New | +$10K | ﹤0.01% | 356 |
|